Both in Pharmaceuticals
Mannkind vs Omeros
Over the past year MNKD returned −28.3% and OMER returned +170.1%; their daily moves had a correlation of 0.06.
MNKD −28.3% OMER +170.1%Growth of $1, one year, split-adjusted
| Metric | MNKD | OMER |
|---|---|---|
| Price | $3.93 | $18.18 |
| Market cap | $1.26B | $1.32B |
| Today | +5.36% | −0.49% |
| 1 month | +5.9% | −1.8% |
| 6 months | +10.4% | +22.6% |
| Year to date | −30.7% | +5.9% |
| 1 year | −28.3% | +153.6% |
| Revenue growth (YoY) | +42.9% | — |
| Gross margin | 73.0% | 97.2% |
| Net margin | −17.4% | 46.4% |
| P/E (TTM) | — | 10.5× |
| Price / sales | 3.2× | 34.3× |
| Net cash | -$373.9M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.3% | 76.7% |
| Short % of float | 8.2% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).